nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—ABCB1—lung cancer	0.178	1	CbGaD
Ranitidine—CYP3A5—Gefitinib—lung cancer	0.0312	0.0551	CbGbCtD
Ranitidine—CYP3A5—Teniposide—lung cancer	0.0303	0.0534	CbGbCtD
Ranitidine—CYP2C19—Gefitinib—lung cancer	0.0252	0.0444	CbGbCtD
Ranitidine—CYP2C19—Teniposide—lung cancer	0.0244	0.0431	CbGbCtD
Ranitidine—ABCB1—Topotecan—lung cancer	0.0222	0.0392	CbGbCtD
Ranitidine—ABCB1—Gefitinib—lung cancer	0.0203	0.0358	CbGbCtD
Ranitidine—CYP2D6—Gefitinib—lung cancer	0.0191	0.0338	CbGbCtD
Ranitidine—CYP3A5—Crizotinib—lung cancer	0.0191	0.0337	CbGbCtD
Ranitidine—SLC22A8—Methotrexate—lung cancer	0.0185	0.0326	CbGbCtD
Ranitidine—CYP3A5—Erlotinib—lung cancer	0.0185	0.0326	CbGbCtD
Ranitidine—CYP3A5—Paclitaxel—lung cancer	0.0169	0.0298	CbGbCtD
Ranitidine—CYP3A5—Irinotecan—lung cancer	0.0167	0.0294	CbGbCtD
Ranitidine—ABCB1—Vinorelbine—lung cancer	0.0157	0.0276	CbGbCtD
Ranitidine—CYP2D6—Vinorelbine—lung cancer	0.0148	0.026	CbGbCtD
Ranitidine—CYP1A2—Erlotinib—lung cancer	0.0137	0.0242	CbGbCtD
Ranitidine—CYP3A5—Etoposide—lung cancer	0.0134	0.0235	CbGbCtD
Ranitidine—CYP3A4—Topotecan—lung cancer	0.0133	0.0235	CbGbCtD
Ranitidine—ABCB1—Crizotinib—lung cancer	0.0125	0.022	CbGbCtD
Ranitidine—CYP3A5—Docetaxel—lung cancer	0.0122	0.0215	CbGbCtD
Ranitidine—CYP3A4—Gefitinib—lung cancer	0.0122	0.0215	CbGbCtD
Ranitidine—ABCB1—Gemcitabine—lung cancer	0.0122	0.0215	CbGbCtD
Ranitidine—ABCB1—Erlotinib—lung cancer	0.012	0.0212	CbGbCtD
Ranitidine—CYP3A4—Teniposide—lung cancer	0.0118	0.0208	CbGbCtD
Ranitidine—CYP2D6—Erlotinib—lung cancer	0.0113	0.02	CbGbCtD
Ranitidine—ABCB1—Paclitaxel—lung cancer	0.011	0.0194	CbGbCtD
Ranitidine—ABCB1—Irinotecan—lung cancer	0.0109	0.0191	CbGbCtD
Ranitidine—CYP1A2—Etoposide—lung cancer	0.00994	0.0175	CbGbCtD
Ranitidine—ABCB1—Vinblastine—lung cancer	0.00965	0.017	CbGbCtD
Ranitidine—CYP3A4—Vinorelbine—lung cancer	0.00938	0.0165	CbGbCtD
Ranitidine—CYP2D6—Vinblastine—lung cancer	0.00909	0.016	CbGbCtD
Ranitidine—ABCB1—Cisplatin—lung cancer	0.00885	0.0156	CbGbCtD
Ranitidine—ABCB1—Etoposide—lung cancer	0.00869	0.0153	CbGbCtD
Ranitidine—ABCB1—Docetaxel—lung cancer	0.00795	0.014	CbGbCtD
Ranitidine—CYP3A4—Crizotinib—lung cancer	0.00746	0.0132	CbGbCtD
Ranitidine—CYP3A4—Erlotinib—lung cancer	0.0072	0.0127	CbGbCtD
Ranitidine—CYP3A4—Paclitaxel—lung cancer	0.00659	0.0116	CbGbCtD
Ranitidine—CYP3A4—Irinotecan—lung cancer	0.0065	0.0115	CbGbCtD
Ranitidine—ABCB1—Doxorubicin—lung cancer	0.00593	0.0105	CbGbCtD
Ranitidine—CYP3A4—Vinblastine—lung cancer	0.00578	0.0102	CbGbCtD
Ranitidine—ABCB1—Methotrexate—lung cancer	0.00574	0.0101	CbGbCtD
Ranitidine—CYP2D6—Doxorubicin—lung cancer	0.00559	0.00985	CbGbCtD
Ranitidine—CYP3A4—Etoposide—lung cancer	0.00521	0.00918	CbGbCtD
Ranitidine—CYP3A4—Docetaxel—lung cancer	0.00476	0.0084	CbGbCtD
Ranitidine—CYP3A4—Doxorubicin—lung cancer	0.00355	0.00626	CbGbCtD
Ranitidine—Nizatidine—ABCB1—lung cancer	0.00207	1	CrCbGaD
Ranitidine—Somnolence—Irinotecan—lung cancer	0.000152	0.000926	CcSEcCtD
Ranitidine—Thrombocytopenia—Cisplatin—lung cancer	0.000152	0.000926	CcSEcCtD
Ranitidine—Headache—Topotecan—lung cancer	0.000152	0.000925	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000152	0.000925	CcSEcCtD
Ranitidine—Tachycardia—Cisplatin—lung cancer	0.000152	0.000923	CcSEcCtD
Ranitidine—Rash—Erlotinib—lung cancer	0.000152	0.000921	CcSEcCtD
Ranitidine—Dermatitis—Erlotinib—lung cancer	0.000151	0.000921	CcSEcCtD
Ranitidine—Insomnia—Gemcitabine—lung cancer	0.000151	0.000918	CcSEcCtD
Ranitidine—Headache—Erlotinib—lung cancer	0.000151	0.000915	CcSEcCtD
Ranitidine—Hyperhidrosis—Cisplatin—lung cancer	0.00015	0.000915	CcSEcCtD
Ranitidine—Arrhythmia—Docetaxel—lung cancer	0.000149	0.000906	CcSEcCtD
Ranitidine—Dyspnoea—Gemcitabine—lung cancer	0.000149	0.000905	CcSEcCtD
Ranitidine—Chest pain—Etoposide—lung cancer	0.000149	0.000904	CcSEcCtD
Ranitidine—Eosinophilia—Methotrexate—lung cancer	0.000149	0.000904	CcSEcCtD
Ranitidine—Nausea—Vinblastine—lung cancer	0.000149	0.000903	CcSEcCtD
Ranitidine—Somnolence—Gemcitabine—lung cancer	0.000148	0.000902	CcSEcCtD
Ranitidine—Alopecia—Docetaxel—lung cancer	0.000147	0.000896	CcSEcCtD
Ranitidine—Pancreatitis—Methotrexate—lung cancer	0.000147	0.000895	CcSEcCtD
Ranitidine—Pruritus—Vinorelbine—lung cancer	0.000147	0.000894	CcSEcCtD
Ranitidine—Discomfort—Etoposide—lung cancer	0.000147	0.000893	CcSEcCtD
Ranitidine—Pain—Irinotecan—lung cancer	0.000147	0.000891	CcSEcCtD
Ranitidine—Constipation—Irinotecan—lung cancer	0.000147	0.000891	CcSEcCtD
Ranitidine—Chest pain—Paclitaxel—lung cancer	0.000146	0.000887	CcSEcCtD
Ranitidine—Myalgia—Paclitaxel—lung cancer	0.000146	0.000887	CcSEcCtD
Ranitidine—Arthralgia—Paclitaxel—lung cancer	0.000146	0.000887	CcSEcCtD
Ranitidine—Hypotension—Cisplatin—lung cancer	0.000145	0.000884	CcSEcCtD
Ranitidine—Erythema—Docetaxel—lung cancer	0.000145	0.000883	CcSEcCtD
Ranitidine—Nausea—Topotecan—lung cancer	0.000144	0.000877	CcSEcCtD
Ranitidine—Discomfort—Paclitaxel—lung cancer	0.000144	0.000876	CcSEcCtD
Ranitidine—Abdominal discomfort—Methotrexate—lung cancer	0.000144	0.000875	CcSEcCtD
Ranitidine—Confusional state—Etoposide—lung cancer	0.000144	0.000874	CcSEcCtD
Ranitidine—Cardiac arrest—Doxorubicin—lung cancer	0.000143	0.00087	CcSEcCtD
Ranitidine—Constipation—Gemcitabine—lung cancer	0.000143	0.000868	CcSEcCtD
Ranitidine—Pain—Gemcitabine—lung cancer	0.000143	0.000868	CcSEcCtD
Ranitidine—Nausea—Erlotinib—lung cancer	0.000143	0.000868	CcSEcCtD
Ranitidine—Pancytopenia—Methotrexate—lung cancer	0.000143	0.000867	CcSEcCtD
Ranitidine—Anaphylactic shock—Etoposide—lung cancer	0.000143	0.000867	CcSEcCtD
Ranitidine—Diarrhoea—Vinorelbine—lung cancer	0.000142	0.000864	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000142	0.000862	CcSEcCtD
Ranitidine—Feeling abnormal—Irinotecan—lung cancer	0.000141	0.000859	CcSEcCtD
Ranitidine—Confusional state—Paclitaxel—lung cancer	0.000141	0.000857	CcSEcCtD
Ranitidine—Blood creatinine increased—Doxorubicin—lung cancer	0.000141	0.000857	CcSEcCtD
Ranitidine—Neutropenia—Methotrexate—lung cancer	0.00014	0.000854	CcSEcCtD
Ranitidine—Anaphylactic shock—Paclitaxel—lung cancer	0.00014	0.00085	CcSEcCtD
Ranitidine—Thrombocytopenia—Etoposide—lung cancer	0.00014	0.000849	CcSEcCtD
Ranitidine—Tachycardia—Etoposide—lung cancer	0.000139	0.000846	CcSEcCtD
Ranitidine—Dyspnoea—Cisplatin—lung cancer	0.000139	0.000843	CcSEcCtD
Ranitidine—Erectile dysfunction—Methotrexate—lung cancer	0.000138	0.000841	CcSEcCtD
Ranitidine—Hyperhidrosis—Etoposide—lung cancer	0.000138	0.000838	CcSEcCtD
Ranitidine—Feeling abnormal—Gemcitabine—lung cancer	0.000138	0.000836	CcSEcCtD
Ranitidine—Dizziness—Vinorelbine—lung cancer	0.000137	0.000836	CcSEcCtD
Ranitidine—Abdominal pain upper—Doxorubicin—lung cancer	0.000137	0.000835	CcSEcCtD
Ranitidine—Photosensitivity reaction—Methotrexate—lung cancer	0.000137	0.000833	CcSEcCtD
Ranitidine—Thrombocytopenia—Paclitaxel—lung cancer	0.000137	0.000832	CcSEcCtD
Ranitidine—Tachycardia—Paclitaxel—lung cancer	0.000136	0.000829	CcSEcCtD
Ranitidine—Breast disorder—Doxorubicin—lung cancer	0.000136	0.000827	CcSEcCtD
Ranitidine—Abdominal pain—Irinotecan—lung cancer	0.000136	0.000824	CcSEcCtD
Ranitidine—Body temperature increased—Irinotecan—lung cancer	0.000136	0.000824	CcSEcCtD
Ranitidine—Hyperhidrosis—Paclitaxel—lung cancer	0.000135	0.000822	CcSEcCtD
Ranitidine—Pneumonia—Methotrexate—lung cancer	0.000135	0.000819	CcSEcCtD
Ranitidine—Anaemia—Docetaxel—lung cancer	0.000134	0.000816	CcSEcCtD
Ranitidine—Hypotension—Etoposide—lung cancer	0.000133	0.00081	CcSEcCtD
Ranitidine—Pain—Cisplatin—lung cancer	0.000133	0.000809	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000133	0.000807	CcSEcCtD
Ranitidine—Vomiting—Vinorelbine—lung cancer	0.000132	0.000803	CcSEcCtD
Ranitidine—Body temperature increased—Gemcitabine—lung cancer	0.000132	0.000802	CcSEcCtD
Ranitidine—Rash—Vinorelbine—lung cancer	0.000131	0.000797	CcSEcCtD
Ranitidine—Dermatitis—Vinorelbine—lung cancer	0.000131	0.000796	CcSEcCtD
Ranitidine—Hypotension—Paclitaxel—lung cancer	0.000131	0.000794	CcSEcCtD
Ranitidine—Headache—Vinorelbine—lung cancer	0.00013	0.000792	CcSEcCtD
Ranitidine—Dysphagia—Doxorubicin—lung cancer	0.00013	0.000791	CcSEcCtD
Ranitidine—Leukopenia—Docetaxel—lung cancer	0.00013	0.00079	CcSEcCtD
Ranitidine—Eosinophilia—Doxorubicin—lung cancer	0.000129	0.000783	CcSEcCtD
Ranitidine—Sweating—Methotrexate—lung cancer	0.000128	0.00078	CcSEcCtD
Ranitidine—Feeling abnormal—Cisplatin—lung cancer	0.000128	0.00078	CcSEcCtD
Ranitidine—Pancreatitis—Doxorubicin—lung cancer	0.000128	0.000775	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000127	0.000774	CcSEcCtD
Ranitidine—Dyspnoea—Etoposide—lung cancer	0.000127	0.000773	CcSEcCtD
Ranitidine—Somnolence—Etoposide—lung cancer	0.000127	0.000771	CcSEcCtD
Ranitidine—Angina pectoris—Doxorubicin—lung cancer	0.000127	0.00077	CcSEcCtD
Ranitidine—Insomnia—Paclitaxel—lung cancer	0.000126	0.000769	CcSEcCtD
Ranitidine—Hypersensitivity—Irinotecan—lung cancer	0.000126	0.000768	CcSEcCtD
Ranitidine—Agranulocytosis—Methotrexate—lung cancer	0.000125	0.00076	CcSEcCtD
Ranitidine—Dyspnoea—Paclitaxel—lung cancer	0.000125	0.000758	CcSEcCtD
Ranitidine—Somnolence—Paclitaxel—lung cancer	0.000124	0.000756	CcSEcCtD
Ranitidine—Arthralgia—Docetaxel—lung cancer	0.000124	0.000751	CcSEcCtD
Ranitidine—Chest pain—Docetaxel—lung cancer	0.000124	0.000751	CcSEcCtD
Ranitidine—Myalgia—Docetaxel—lung cancer	0.000124	0.000751	CcSEcCtD
Ranitidine—Pancytopenia—Doxorubicin—lung cancer	0.000124	0.000751	CcSEcCtD
Ranitidine—Nausea—Vinorelbine—lung cancer	0.000123	0.00075	CcSEcCtD
Ranitidine—Body temperature increased—Cisplatin—lung cancer	0.000123	0.000748	CcSEcCtD
Ranitidine—Constipation—Etoposide—lung cancer	0.000122	0.000741	CcSEcCtD
Ranitidine—Pain—Etoposide—lung cancer	0.000122	0.000741	CcSEcCtD
Ranitidine—Neutropenia—Doxorubicin—lung cancer	0.000122	0.000739	CcSEcCtD
Ranitidine—Hepatitis—Methotrexate—lung cancer	0.00012	0.000731	CcSEcCtD
Ranitidine—Pain—Paclitaxel—lung cancer	0.00012	0.000727	CcSEcCtD
Ranitidine—Constipation—Paclitaxel—lung cancer	0.00012	0.000727	CcSEcCtD
Ranitidine—Confusional state—Docetaxel—lung cancer	0.000119	0.000726	CcSEcCtD
Ranitidine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000119	0.000722	CcSEcCtD
Ranitidine—Anaphylactic shock—Docetaxel—lung cancer	0.000119	0.00072	CcSEcCtD
Ranitidine—Pruritus—Gemcitabine—lung cancer	0.000118	0.000718	CcSEcCtD
Ranitidine—Weight decreased—Doxorubicin—lung cancer	0.000118	0.000715	CcSEcCtD
Ranitidine—Feeling abnormal—Etoposide—lung cancer	0.000118	0.000714	CcSEcCtD
Ranitidine—Diarrhoea—Irinotecan—lung cancer	0.000117	0.000713	CcSEcCtD
Ranitidine—Pneumonia—Doxorubicin—lung cancer	0.000117	0.000709	CcSEcCtD
Ranitidine—Thrombocytopenia—Docetaxel—lung cancer	0.000116	0.000705	CcSEcCtD
Ranitidine—Tachycardia—Docetaxel—lung cancer	0.000116	0.000703	CcSEcCtD
Ranitidine—Feeling abnormal—Paclitaxel—lung cancer	0.000115	0.0007	CcSEcCtD
Ranitidine—Hypersensitivity—Cisplatin—lung cancer	0.000115	0.000697	CcSEcCtD
Ranitidine—Diarrhoea—Gemcitabine—lung cancer	0.000114	0.000695	CcSEcCtD
Ranitidine—Erythema multiforme—Methotrexate—lung cancer	0.000114	0.000691	CcSEcCtD
Ranitidine—Dizziness—Irinotecan—lung cancer	0.000113	0.000689	CcSEcCtD
Ranitidine—Urticaria—Etoposide—lung cancer	0.000113	0.000689	CcSEcCtD
Ranitidine—Jaundice—Doxorubicin—lung cancer	0.000113	0.000687	CcSEcCtD
Ranitidine—Abdominal pain—Etoposide—lung cancer	0.000113	0.000685	CcSEcCtD
Ranitidine—Body temperature increased—Etoposide—lung cancer	0.000113	0.000685	CcSEcCtD
Ranitidine—Sweating—Doxorubicin—lung cancer	0.000111	0.000676	CcSEcCtD
Ranitidine—Urticaria—Paclitaxel—lung cancer	0.000111	0.000675	CcSEcCtD
Ranitidine—Hypotension—Docetaxel—lung cancer	0.000111	0.000673	CcSEcCtD
Ranitidine—Abdominal pain—Paclitaxel—lung cancer	0.000111	0.000672	CcSEcCtD
Ranitidine—Body temperature increased—Paclitaxel—lung cancer	0.000111	0.000672	CcSEcCtD
Ranitidine—Vomiting—Irinotecan—lung cancer	0.000109	0.000663	CcSEcCtD
Ranitidine—Agranulocytosis—Doxorubicin—lung cancer	0.000108	0.000658	CcSEcCtD
Ranitidine—Rash—Irinotecan—lung cancer	0.000108	0.000657	CcSEcCtD
Ranitidine—Dermatitis—Irinotecan—lung cancer	0.000108	0.000656	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000108	0.000656	CcSEcCtD
Ranitidine—Headache—Irinotecan—lung cancer	0.000107	0.000653	CcSEcCtD
Ranitidine—Insomnia—Docetaxel—lung cancer	0.000107	0.000652	CcSEcCtD
Ranitidine—Diarrhoea—Cisplatin—lung cancer	0.000106	0.000647	CcSEcCtD
Ranitidine—Alopecia—Methotrexate—lung cancer	0.000106	0.000646	CcSEcCtD
Ranitidine—Vomiting—Gemcitabine—lung cancer	0.000106	0.000645	CcSEcCtD
Ranitidine—Bradycardia—Doxorubicin—lung cancer	0.000106	0.000644	CcSEcCtD
Ranitidine—Dyspnoea—Docetaxel—lung cancer	0.000106	0.000642	CcSEcCtD
Ranitidine—Somnolence—Docetaxel—lung cancer	0.000105	0.00064	CcSEcCtD
Ranitidine—Rash—Gemcitabine—lung cancer	0.000105	0.00064	CcSEcCtD
Ranitidine—Dermatitis—Gemcitabine—lung cancer	0.000105	0.000639	CcSEcCtD
Ranitidine—Hypersensitivity—Etoposide—lung cancer	0.000105	0.000639	CcSEcCtD
Ranitidine—Erythema—Methotrexate—lung cancer	0.000105	0.000636	CcSEcCtD
Ranitidine—Headache—Gemcitabine—lung cancer	0.000105	0.000636	CcSEcCtD
Ranitidine—Hepatitis—Doxorubicin—lung cancer	0.000104	0.000633	CcSEcCtD
Ranitidine—Hypersensitivity—Paclitaxel—lung cancer	0.000103	0.000626	CcSEcCtD
Ranitidine—Nausea—Irinotecan—lung cancer	0.000102	0.000619	CcSEcCtD
Ranitidine—Constipation—Docetaxel—lung cancer	0.000101	0.000616	CcSEcCtD
Ranitidine—Pain—Docetaxel—lung cancer	0.000101	0.000616	CcSEcCtD
Ranitidine—Pruritus—Etoposide—lung cancer	0.000101	0.000613	CcSEcCtD
Ranitidine—Nausea—Gemcitabine—lung cancer	9.92e-05	0.000603	CcSEcCtD
Ranitidine—Vomiting—Cisplatin—lung cancer	9.9e-05	0.000602	CcSEcCtD
Ranitidine—Pruritus—Paclitaxel—lung cancer	9.89e-05	0.000601	CcSEcCtD
Ranitidine—Vision blurred—Methotrexate—lung cancer	9.86e-05	0.0006	CcSEcCtD
Ranitidine—Erythema multiforme—Doxorubicin—lung cancer	9.84e-05	0.000598	CcSEcCtD
Ranitidine—Rash—Cisplatin—lung cancer	9.81e-05	0.000597	CcSEcCtD
Ranitidine—Dermatitis—Cisplatin—lung cancer	9.8e-05	0.000596	CcSEcCtD
Ranitidine—Feeling abnormal—Docetaxel—lung cancer	9.77e-05	0.000594	CcSEcCtD
Ranitidine—Diarrhoea—Etoposide—lung cancer	9.76e-05	0.000593	CcSEcCtD
Ranitidine—Ill-defined disorder—Methotrexate—lung cancer	9.71e-05	0.00059	CcSEcCtD
Ranitidine—Anaemia—Methotrexate—lung cancer	9.67e-05	0.000588	CcSEcCtD
Ranitidine—Diarrhoea—Paclitaxel—lung cancer	9.57e-05	0.000581	CcSEcCtD
Ranitidine—Malaise—Methotrexate—lung cancer	9.44e-05	0.000574	CcSEcCtD
Ranitidine—Dizziness—Etoposide—lung cancer	9.43e-05	0.000573	CcSEcCtD
Ranitidine—Vertigo—Methotrexate—lung cancer	9.4e-05	0.000572	CcSEcCtD
Ranitidine—Abdominal pain—Docetaxel—lung cancer	9.37e-05	0.000569	CcSEcCtD
Ranitidine—Body temperature increased—Docetaxel—lung cancer	9.37e-05	0.000569	CcSEcCtD
Ranitidine—Leukopenia—Methotrexate—lung cancer	9.37e-05	0.000569	CcSEcCtD
Ranitidine—Arrhythmia—Doxorubicin—lung cancer	9.3e-05	0.000565	CcSEcCtD
Ranitidine—Dizziness—Paclitaxel—lung cancer	9.25e-05	0.000562	CcSEcCtD
Ranitidine—Nausea—Cisplatin—lung cancer	9.25e-05	0.000562	CcSEcCtD
Ranitidine—Alopecia—Doxorubicin—lung cancer	9.2e-05	0.000559	CcSEcCtD
Ranitidine—Vomiting—Etoposide—lung cancer	9.07e-05	0.000551	CcSEcCtD
Ranitidine—Erythema—Doxorubicin—lung cancer	9.06e-05	0.000551	CcSEcCtD
Ranitidine—Rash—Etoposide—lung cancer	8.99e-05	0.000547	CcSEcCtD
Ranitidine—Dermatitis—Etoposide—lung cancer	8.98e-05	0.000546	CcSEcCtD
Ranitidine—Headache—Etoposide—lung cancer	8.93e-05	0.000543	CcSEcCtD
Ranitidine—Myalgia—Methotrexate—lung cancer	8.91e-05	0.000542	CcSEcCtD
Ranitidine—Chest pain—Methotrexate—lung cancer	8.91e-05	0.000542	CcSEcCtD
Ranitidine—Arthralgia—Methotrexate—lung cancer	8.91e-05	0.000542	CcSEcCtD
Ranitidine—Vomiting—Paclitaxel—lung cancer	8.89e-05	0.00054	CcSEcCtD
Ranitidine—Rash—Paclitaxel—lung cancer	8.82e-05	0.000536	CcSEcCtD
Ranitidine—Dermatitis—Paclitaxel—lung cancer	8.81e-05	0.000535	CcSEcCtD
Ranitidine—Discomfort—Methotrexate—lung cancer	8.8e-05	0.000535	CcSEcCtD
Ranitidine—Headache—Paclitaxel—lung cancer	8.76e-05	0.000532	CcSEcCtD
Ranitidine—Hypersensitivity—Docetaxel—lung cancer	8.73e-05	0.000531	CcSEcCtD
Ranitidine—Confusional state—Methotrexate—lung cancer	8.61e-05	0.000523	CcSEcCtD
Ranitidine—Anaphylactic shock—Methotrexate—lung cancer	8.54e-05	0.000519	CcSEcCtD
Ranitidine—Vision blurred—Doxorubicin—lung cancer	8.54e-05	0.000519	CcSEcCtD
Ranitidine—Nausea—Etoposide—lung cancer	8.47e-05	0.000515	CcSEcCtD
Ranitidine—Ill-defined disorder—Doxorubicin—lung cancer	8.41e-05	0.000511	CcSEcCtD
Ranitidine—Pruritus—Docetaxel—lung cancer	8.38e-05	0.00051	CcSEcCtD
Ranitidine—Anaemia—Doxorubicin—lung cancer	8.38e-05	0.000509	CcSEcCtD
Ranitidine—Thrombocytopenia—Methotrexate—lung cancer	8.36e-05	0.000508	CcSEcCtD
Ranitidine—Agitation—Doxorubicin—lung cancer	8.33e-05	0.000506	CcSEcCtD
Ranitidine—Nausea—Paclitaxel—lung cancer	8.3e-05	0.000505	CcSEcCtD
Ranitidine—Hyperhidrosis—Methotrexate—lung cancer	8.26e-05	0.000502	CcSEcCtD
Ranitidine—Malaise—Doxorubicin—lung cancer	8.17e-05	0.000497	CcSEcCtD
Ranitidine—Vertigo—Doxorubicin—lung cancer	8.14e-05	0.000495	CcSEcCtD
Ranitidine—Leukopenia—Doxorubicin—lung cancer	8.11e-05	0.000493	CcSEcCtD
Ranitidine—Diarrhoea—Docetaxel—lung cancer	8.11e-05	0.000493	CcSEcCtD
Ranitidine—Hypotension—Methotrexate—lung cancer	7.98e-05	0.000485	CcSEcCtD
Ranitidine—Dizziness—Docetaxel—lung cancer	7.84e-05	0.000476	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Methotrexate—lung cancer	7.78e-05	0.000473	CcSEcCtD
Ranitidine—Insomnia—Methotrexate—lung cancer	7.72e-05	0.00047	CcSEcCtD
Ranitidine—Arthralgia—Doxorubicin—lung cancer	7.71e-05	0.000469	CcSEcCtD
Ranitidine—Myalgia—Doxorubicin—lung cancer	7.71e-05	0.000469	CcSEcCtD
Ranitidine—Chest pain—Doxorubicin—lung cancer	7.71e-05	0.000469	CcSEcCtD
Ranitidine—Discomfort—Doxorubicin—lung cancer	7.62e-05	0.000463	CcSEcCtD
Ranitidine—Dyspnoea—Methotrexate—lung cancer	7.61e-05	0.000463	CcSEcCtD
Ranitidine—Somnolence—Methotrexate—lung cancer	7.59e-05	0.000462	CcSEcCtD
Ranitidine—Vomiting—Docetaxel—lung cancer	7.53e-05	0.000458	CcSEcCtD
Ranitidine—Rash—Docetaxel—lung cancer	7.47e-05	0.000454	CcSEcCtD
Ranitidine—Dermatitis—Docetaxel—lung cancer	7.46e-05	0.000454	CcSEcCtD
Ranitidine—Confusional state—Doxorubicin—lung cancer	7.46e-05	0.000453	CcSEcCtD
Ranitidine—Headache—Docetaxel—lung cancer	7.42e-05	0.000451	CcSEcCtD
Ranitidine—Anaphylactic shock—Doxorubicin—lung cancer	7.4e-05	0.00045	CcSEcCtD
Ranitidine—Pain—Methotrexate—lung cancer	7.3e-05	0.000444	CcSEcCtD
Ranitidine—Thrombocytopenia—Doxorubicin—lung cancer	7.24e-05	0.00044	CcSEcCtD
Ranitidine—Tachycardia—Doxorubicin—lung cancer	7.22e-05	0.000439	CcSEcCtD
Ranitidine—Hyperhidrosis—Doxorubicin—lung cancer	7.15e-05	0.000435	CcSEcCtD
Ranitidine—Nausea—Docetaxel—lung cancer	7.04e-05	0.000428	CcSEcCtD
Ranitidine—Feeling abnormal—Methotrexate—lung cancer	7.04e-05	0.000428	CcSEcCtD
Ranitidine—Hypotension—Doxorubicin—lung cancer	6.91e-05	0.00042	CcSEcCtD
Ranitidine—Urticaria—Methotrexate—lung cancer	6.79e-05	0.000412	CcSEcCtD
Ranitidine—Abdominal pain—Methotrexate—lung cancer	6.75e-05	0.00041	CcSEcCtD
Ranitidine—Body temperature increased—Methotrexate—lung cancer	6.75e-05	0.00041	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.74e-05	0.00041	CcSEcCtD
Ranitidine—Insomnia—Doxorubicin—lung cancer	6.69e-05	0.000407	CcSEcCtD
Ranitidine—Dyspnoea—Doxorubicin—lung cancer	6.59e-05	0.000401	CcSEcCtD
Ranitidine—Somnolence—Doxorubicin—lung cancer	6.57e-05	0.0004	CcSEcCtD
Ranitidine—Constipation—Doxorubicin—lung cancer	6.32e-05	0.000384	CcSEcCtD
Ranitidine—Pain—Doxorubicin—lung cancer	6.32e-05	0.000384	CcSEcCtD
Ranitidine—Hypersensitivity—Methotrexate—lung cancer	6.29e-05	0.000383	CcSEcCtD
Ranitidine—Feeling abnormal—Doxorubicin—lung cancer	6.09e-05	0.00037	CcSEcCtD
Ranitidine—Pruritus—Methotrexate—lung cancer	6.04e-05	0.000367	CcSEcCtD
Ranitidine—Urticaria—Doxorubicin—lung cancer	5.88e-05	0.000357	CcSEcCtD
Ranitidine—Abdominal pain—Doxorubicin—lung cancer	5.85e-05	0.000355	CcSEcCtD
Ranitidine—Body temperature increased—Doxorubicin—lung cancer	5.85e-05	0.000355	CcSEcCtD
Ranitidine—Diarrhoea—Methotrexate—lung cancer	5.84e-05	0.000355	CcSEcCtD
Ranitidine—Dizziness—Methotrexate—lung cancer	5.65e-05	0.000343	CcSEcCtD
Ranitidine—Hypersensitivity—Doxorubicin—lung cancer	5.45e-05	0.000331	CcSEcCtD
Ranitidine—Vomiting—Methotrexate—lung cancer	5.43e-05	0.00033	CcSEcCtD
Ranitidine—Rash—Methotrexate—lung cancer	5.39e-05	0.000327	CcSEcCtD
Ranitidine—Dermatitis—Methotrexate—lung cancer	5.38e-05	0.000327	CcSEcCtD
Ranitidine—Headache—Methotrexate—lung cancer	5.35e-05	0.000325	CcSEcCtD
Ranitidine—Pruritus—Doxorubicin—lung cancer	5.23e-05	0.000318	CcSEcCtD
Ranitidine—Nausea—Methotrexate—lung cancer	5.07e-05	0.000308	CcSEcCtD
Ranitidine—Diarrhoea—Doxorubicin—lung cancer	5.06e-05	0.000308	CcSEcCtD
Ranitidine—Dizziness—Doxorubicin—lung cancer	4.89e-05	0.000297	CcSEcCtD
Ranitidine—Vomiting—Doxorubicin—lung cancer	4.7e-05	0.000286	CcSEcCtD
Ranitidine—Rash—Doxorubicin—lung cancer	4.66e-05	0.000283	CcSEcCtD
Ranitidine—Dermatitis—Doxorubicin—lung cancer	4.66e-05	0.000283	CcSEcCtD
Ranitidine—Headache—Doxorubicin—lung cancer	4.63e-05	0.000282	CcSEcCtD
Ranitidine—Nausea—Doxorubicin—lung cancer	4.39e-05	0.000267	CcSEcCtD
Ranitidine—CYP2C19—Metabolism—GSTT1—lung cancer	9.61e-06	0.000109	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ERCC2—lung cancer	9.59e-06	0.000109	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NCOA3—lung cancer	9.56e-06	0.000108	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CA—lung cancer	9.51e-06	0.000108	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GCLC—lung cancer	9.5e-06	0.000108	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP2A6—lung cancer	9.5e-06	0.000108	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MDM2—lung cancer	9.47e-06	0.000107	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.47e-06	0.000107	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RAF1—lung cancer	9.44e-06	0.000107	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTT1—lung cancer	9.38e-06	0.000106	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—AKR1C1—lung cancer	9.36e-06	0.000106	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ERBB2—lung cancer	9.34e-06	0.000106	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—STK11—lung cancer	9.32e-06	0.000106	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ABCG2—lung cancer	9.3e-06	0.000105	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ADCY1—lung cancer	9.3e-06	0.000105	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GCLC—lung cancer	9.28e-06	0.000105	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP2A6—lung cancer	9.28e-06	0.000105	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MTOR—lung cancer	9.22e-06	0.000105	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CB—lung cancer	9.22e-06	0.000105	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—HPGDS—lung cancer	9.12e-06	0.000103	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ENO2—lung cancer	9.12e-06	0.000103	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	9.11e-06	0.000103	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—UGT1A1—lung cancer	9.08e-06	0.000103	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PPP2R1B—lung cancer	9.06e-06	0.000103	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ENO1—lung cancer	9.01e-06	0.000102	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.98e-06	0.000102	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.86e-06	0.0001	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCL8—lung cancer	8.86e-06	0.0001	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTT1—lung cancer	8.84e-06	0.0001	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—HRAS—lung cancer	8.8e-06	9.98e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ENO1—lung cancer	8.79e-06	9.97e-05	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	8.79e-06	9.96e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—RRM1—lung cancer	8.77e-06	9.94e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTA3—lung cancer	8.77e-06	9.94e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GNG11—lung cancer	8.76e-06	9.93e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GCLC—lung cancer	8.74e-06	9.91e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP2A6—lung cancer	8.74e-06	9.91e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	8.71e-06	9.88e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTP1—lung cancer	8.62e-06	9.78e-05	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—AKT1—lung cancer	8.56e-06	9.7e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CASP3—lung cancer	8.48e-06	9.61e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL2—lung cancer	8.46e-06	9.6e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL6—lung cancer	8.42e-06	9.55e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CAT—lung cancer	8.39e-06	9.51e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ALDOA—lung cancer	8.34e-06	9.46e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—APOA1—lung cancer	8.29e-06	9.41e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ENO1—lung cancer	8.29e-06	9.4e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCND1—lung cancer	8.25e-06	9.36e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—B4GALT5—lung cancer	8.24e-06	9.35e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—JUN—lung cancer	8.23e-06	9.34e-05	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	8.22e-06	9.33e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ABCB1—lung cancer	8.16e-06	9.25e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NCOA3—lung cancer	8.1e-06	9.18e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP2E1—lung cancer	8.08e-06	9.16e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTA4—lung cancer	8.02e-06	9.1e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—TYMS—lung cancer	8.01e-06	9.09e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MMP9—lung cancer	8.01e-06	9.08e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NQO1—lung cancer	7.99e-06	9.06e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CDKN1A—lung cancer	7.98e-06	9.05e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTEN—lung cancer	7.96e-06	9.03e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.96e-06	9.02e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTM1—lung cancer	7.92e-06	8.98e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP2E1—lung cancer	7.89e-06	8.94e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ABCG2—lung cancer	7.88e-06	8.93e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ADCY1—lung cancer	7.88e-06	8.93e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.82e-06	8.87e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTA2—lung cancer	7.82e-06	8.86e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NQO1—lung cancer	7.8e-06	8.84e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AKT1—lung cancer	7.77e-06	8.81e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.75e-06	8.79e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—HPGDS—lung cancer	7.72e-06	8.76e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ENO2—lung cancer	7.72e-06	8.76e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PPP2R1B—lung cancer	7.68e-06	8.7e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EP300—lung cancer	7.6e-06	8.61e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.57e-06	8.59e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CG—lung cancer	7.57e-06	8.59e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTA1—lung cancer	7.54e-06	8.55e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP1A1—lung cancer	7.51e-06	8.52e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTT1—lung cancer	7.49e-06	8.5e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ABCC3—lung cancer	7.46e-06	8.46e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ERCC2—lung cancer	7.45e-06	8.45e-05	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	7.44e-06	8.43e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP2E1—lung cancer	7.43e-06	8.43e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP2A6—lung cancer	7.4e-06	8.4e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GCLC—lung cancer	7.4e-06	8.4e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SRC—lung cancer	7.39e-06	8.38e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.38e-06	8.37e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NQO1—lung cancer	7.35e-06	8.33e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AKR1C1—lung cancer	7.22e-06	8.19e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—POMC—lung cancer	7.21e-06	8.17e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—STK11—lung cancer	7.2e-06	8.17e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VEGFA—lung cancer	7.19e-06	8.16e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT3—lung cancer	7.12e-06	8.08e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NRAS—lung cancer	7.11e-06	8.06e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—STK11—lung cancer	7.03e-06	7.97e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CREBBP—lung cancer	7.02e-06	7.96e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ENO1—lung cancer	7.02e-06	7.96e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—UGT1A1—lung cancer	7.01e-06	7.95e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.99e-06	7.93e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.9e-06	7.83e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MAPK3—lung cancer	6.8e-06	7.72e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.76e-06	7.67e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GNG11—lung cancer	6.76e-06	7.67e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTP1—lung cancer	6.66e-06	7.56e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CD—lung cancer	6.66e-06	7.55e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—STK11—lung cancer	6.62e-06	7.51e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MYC—lung cancer	6.62e-06	7.51e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ALB—lung cancer	6.57e-06	7.45e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTP1—lung cancer	6.5e-06	7.38e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CAT—lung cancer	6.48e-06	7.35e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGFR—lung cancer	6.47e-06	7.34e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.45e-06	7.31e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—APOA1—lung cancer	6.44e-06	7.31e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ALDOA—lung cancer	6.44e-06	7.3e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CAT—lung cancer	6.33e-06	7.18e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ABCB1—lung cancer	6.31e-06	7.15e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP2E1—lung cancer	6.3e-06	7.14e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOA3—lung cancer	6.25e-06	7.09e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NQO1—lung cancer	6.23e-06	7.06e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TYMS—lung cancer	6.2e-06	7.03e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTP1—lung cancer	6.13e-06	6.95e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTM1—lung cancer	6.12e-06	6.94e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KRAS—lung cancer	6.12e-06	6.93e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.1e-06	6.91e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ABCG2—lung cancer	6.08e-06	6.89e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ADCY1—lung cancer	6.08e-06	6.89e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TYMS—lung cancer	6.05e-06	6.86e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.04e-06	6.85e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTM1—lung cancer	5.98e-06	6.78e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CAT—lung cancer	5.96e-06	6.76e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HPGDS—lung cancer	5.96e-06	6.76e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ENO2—lung cancer	5.96e-06	6.76e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.92e-06	6.72e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CG—lung cancer	5.88e-06	6.67e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP1A1—lung cancer	5.81e-06	6.58e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CB—lung cancer	5.8e-06	6.58e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ABCB1—lung cancer	5.8e-06	6.58e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTT1—lung cancer	5.78e-06	6.56e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ERCC2—lung cancer	5.76e-06	6.53e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTGS2—lung cancer	5.75e-06	6.52e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GCLC—lung cancer	5.71e-06	6.48e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP2A6—lung cancer	5.71e-06	6.48e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TYMS—lung cancer	5.7e-06	6.46e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP1A1—lung cancer	5.67e-06	6.43e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTM1—lung cancer	5.63e-06	6.39e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ERCC2—lung cancer	5.62e-06	6.37e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CA—lung cancer	5.62e-06	6.37e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—STK11—lung cancer	5.61e-06	6.36e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—POMC—lung cancer	5.6e-06	6.35e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CREBBP—lung cancer	5.45e-06	6.18e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—lung cancer	5.44e-06	6.16e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ENO1—lung cancer	5.42e-06	6.14e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP1A1—lung cancer	5.34e-06	6.06e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ERCC2—lung cancer	5.3e-06	6.01e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.27e-06	5.97e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HRAS—lung cancer	5.2e-06	5.89e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTP1—lung cancer	5.19e-06	5.89e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CD—lung cancer	5.17e-06	5.86e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ALB—lung cancer	5.1e-06	5.79e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CAT—lung cancer	5.05e-06	5.73e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.02e-06	5.7e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTEN—lung cancer	5.01e-06	5.69e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—APOA1—lung cancer	4.98e-06	5.65e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL6—lung cancer	4.98e-06	5.64e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ABCB1—lung cancer	4.92e-06	5.57e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—APOA1—lung cancer	4.86e-06	5.51e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP2E1—lung cancer	4.86e-06	5.51e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TYMS—lung cancer	4.83e-06	5.47e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NQO1—lung cancer	4.8e-06	5.45e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—EP300—lung cancer	4.78e-06	5.42e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTM1—lung cancer	4.77e-06	5.41e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.77e-06	5.41e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AKT1—lung cancer	4.59e-06	5.2e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—APOA1—lung cancer	4.58e-06	5.2e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CG—lung cancer	4.55e-06	5.16e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP1A1—lung cancer	4.52e-06	5.13e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CB—lung cancer	4.51e-06	5.11e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ERCC2—lung cancer	4.49e-06	5.09e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTGS2—lung cancer	4.47e-06	5.06e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CG—lung cancer	4.44e-06	5.03e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—STK11—lung cancer	4.33e-06	4.91e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—POMC—lung cancer	4.33e-06	4.91e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—POMC—lung cancer	4.22e-06	4.79e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CREBBP—lung cancer	4.22e-06	4.78e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CG—lung cancer	4.18e-06	4.74e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CREBBP—lung cancer	4.12e-06	4.67e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTP1—lung cancer	4.01e-06	4.54e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CD—lung cancer	4e-06	4.53e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—POMC—lung cancer	3.98e-06	4.51e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ALB—lung cancer	3.95e-06	4.48e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CD—lung cancer	3.9e-06	4.42e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CAT—lung cancer	3.9e-06	4.42e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTEN—lung cancer	3.89e-06	4.42e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—APOA1—lung cancer	3.88e-06	4.4e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CREBBP—lung cancer	3.88e-06	4.4e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ALB—lung cancer	3.85e-06	4.37e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ABCB1—lung cancer	3.79e-06	4.3e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TYMS—lung cancer	3.73e-06	4.22e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.72e-06	4.21e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—EP300—lung cancer	3.71e-06	4.21e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTM1—lung cancer	3.68e-06	4.18e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CD—lung cancer	3.68e-06	4.17e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ALB—lung cancer	3.63e-06	4.12e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CG—lung cancer	3.54e-06	4.02e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CA—lung cancer	3.54e-06	4.01e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP1A1—lung cancer	3.49e-06	3.96e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CB—lung cancer	3.48e-06	3.95e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ERCC2—lung cancer	3.46e-06	3.93e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTGS2—lung cancer	3.45e-06	3.92e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CB—lung cancer	3.4e-06	3.86e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—POMC—lung cancer	3.37e-06	3.82e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTGS2—lung cancer	3.37e-06	3.82e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CREBBP—lung cancer	3.29e-06	3.73e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CB—lung cancer	3.2e-06	3.63e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTGS2—lung cancer	3.18e-06	3.6e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CD—lung cancer	3.11e-06	3.53e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ALB—lung cancer	3.07e-06	3.49e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTEN—lung cancer	3.01e-06	3.41e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—APOA1—lung cancer	3e-06	3.4e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTEN—lung cancer	2.94e-06	3.33e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—AKT1—lung cancer	2.89e-06	3.28e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—EP300—lung cancer	2.87e-06	3.26e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—EP300—lung cancer	2.8e-06	3.18e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTEN—lung cancer	2.77e-06	3.14e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CA—lung cancer	2.75e-06	3.12e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CG—lung cancer	2.73e-06	3.1e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CB—lung cancer	2.71e-06	3.08e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS2—lung cancer	2.69e-06	3.05e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—EP300—lung cancer	2.64e-06	2.99e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—POMC—lung cancer	2.6e-06	2.95e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CREBBP—lung cancer	2.54e-06	2.88e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CD—lung cancer	2.4e-06	2.73e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ALB—lung cancer	2.37e-06	2.69e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTEN—lung cancer	2.35e-06	2.66e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—AKT1—lung cancer	2.24e-06	2.55e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—EP300—lung cancer	2.24e-06	2.54e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CA—lung cancer	2.12e-06	2.41e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.1e-06	2.38e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS2—lung cancer	2.08e-06	2.35e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CA—lung cancer	2.07e-06	2.35e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.95e-06	2.22e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTEN—lung cancer	1.81e-06	2.05e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—AKT1—lung cancer	1.74e-06	1.97e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—EP300—lung cancer	1.73e-06	1.96e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—AKT1—lung cancer	1.69e-06	1.92e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CA—lung cancer	1.66e-06	1.88e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—AKT1—lung cancer	1.6e-06	1.81e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—AKT1—lung cancer	1.35e-06	1.53e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.28e-06	1.45e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AKT1—lung cancer	1.04e-06	1.18e-05	CbGpPWpGaD
